This is a Notice of Intent to sole source the procurement of Sirturo (Bedaquiline) tablets to Cardinal Health, as they are the manufacturer's designated sole distributor. The requirement is for annual quantities of approximately 12-36 bottles each of 100mg and 20mg tablet bottles. Delivery is required within 30 days of award to the NIH Clinical Center in Bethesda, MD. The justification is that there are no therapeutic substitutes and only Cardinal Health is an authorized source. This notice is not a request for proposals, but capability statements may be submitted for government consideration.